nach oben

Erschienen in:

05.06.2018 | Original articles

Balloon sizing during transcatheter aortic valve implantation

Comparison of different valve morphologies

verfasst von: Y.-N. Xu, MD, T.-Y. Xiong, MD, Y.-J. Li, MD, Y.-B. Liao, MD, Z.-G. Zhao, MD, X. Wei, MD, Y. Feng, MD, M. Chen, MD, PhD

Erschienen in: Herz | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Although balloon sizing has been found to be useful during transcatheter aortic valve implantation (TAVI), its effectiveness in patients with bicuspid aortic valve (BiAV) remains unknown.

Methods

Patients who underwent balloon sizing were retrospectively identified. The study comprised 67 patients (61.2% with BiAV). Preprocedural hypothetical transcatheter heart valve (THV) sizing was based on multislice computed tomography (MSCT) measurements at the annulus. Changes in valve size after balloon sizing were reviewed. Postprocedural MSCT measurements and the grade of paravalvular aortic regurgitation (PAR) were compared.

Results

When comparing patients with a BiAV and those with a tricuspid aortic valve (TiAV), there was no significant difference (p = 0.97) in the proportion of decreased (43.9% vs. 46.2%), unchanged (51.2% vs. 50.0%), or increased (4.9% vs. 3.8%) valve sizes chosen on the basis of MSCT findings. The anticipated annular sizing ratio for patients who received a smaller valve was 7.2% (3.5–10.5%) while it was 15.7% (12.5–19.0) for the others (p < 0.01), and no significant difference in the proportion of mild (or more severe) PAR cases was found between the groups (37.9% vs. 30.6%, p = 0.53 at the 1‑month follow-up). Stent frame expansion and eccentricity index were comparable between the BiAV and TiAV subgroups among patients who received a smaller THV after balloon sizing.

Conclusion

Balloon sizing is a useful tool that is complementary to the current gold standard of MSCT for THV size selection as well as for BiAV morphology assessment.

Serfaty JM, Himbert D, Esposito-Farese M et al (2014) Measurement of the aortic annulus diameter using transesophageal echocardiography and multislice computed tomography—are they truly comparable? Can J Cardiol 30:1073–1079. https://doi.org/10.1016/j.cjca.2014.06.012CrossRef

Barbanti M, Yang T‑H, Rodes Cabau J et al (2013) Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 128:244–253. https://doi.org/10.1161/CIRCULATIONAHA.113.002947 CrossRefPubMed

Gilard M, Eltchaninoff H, Iung B et al (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715. https://doi.org/10.1056/NEJMoa1114705 CrossRefPubMed

Babaliaros V (2013) To size or not to size—there is no question: balloon sizing for transcatheter aortic valve replacement. JACC Cardiovasc Interv 6:972–973. https://doi.org/10.1016/j.jcin.2013.06.005 CrossRefPubMed

Jilaihawi H, Wu Y, Yang Y et al (2015) Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter Cardiovasc Interv 1:752–761. https://doi.org/10.1002/ccd.25863 CrossRef

Grube E, Laborde JC, Gerckens U et al (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114:1616–1624. https://doi.org/10.1161/CIRCULATIONAHA.106.639450 CrossRefPubMed

Petronio AS, De Carlo M, Bedogni F et al (2010) Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 3:359–366. https://doi.org/10.1161/CIRCINTERVENTIONS.109.930453 CrossRefPubMed

Kappetein AP, Head SJ, Genereux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur J Cardiothorac Surg 8:782–795. https://doi.org/10.4244/EIJV8I7A121 CrossRef

Guo Y, Yang Z, Shao H et al (2013) Right ventricular dysfunction and dilatation in patients with mitral regurgitation: analysis using ECG-gated multidetector row computed tomography. Int J Cardiol 167:1585–1590. https://doi.org/10.1016/j.ijcard.2012.04.104 CrossRefPubMed

10.

Cerillo AG, Mariani M, Berti S, Glauber M (2012) Sizing the aortic annulus. Ann Cardiothorac Surg 1:245–256. https://doi.org/10.3978/j.issn.2225-319X.2012.06.13 CrossRefPubMedPubMedCentral

11.

Kasel AM, Cassese S, Bleiziffer S et al (2013) Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging 6:249–262. https://doi.org/10.1016/j.jcmg.2012.12.005 CrossRefPubMed

12.

Patsalis PC, Al-Rashid F, Neumann T et al (2013) Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing. JACC Cardiovasc Interv. https://doi.org/10.1016/j.jcin.2013.05.006 CrossRefPubMed

13.

Oh JK, Little SH, Abdelmoneim SS et al (2015) Regression of Paravalvular aortic regurgitation and remodeling of self-expanding transcatheter aortic valve: an observation from the corevalve U.S. Pivotal trial. J Am Coll Cardiol Img. https://doi.org/10.1016/j.jcmg.2015.07.012 CrossRef

14.

Schultz CJ, Weustink A, Piazza N et al (2009) Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. J Am Coll Cardiol 54:911–918. https://doi.org/10.1016/j.jacc.2009.04.075 CrossRefPubMed

15.

Kazuno Y, Maeno Y, Kawamori H et al (2016) Comparison of SAPIEN 3 and SAPIEN XT transcatheter heart valve stent-frame expansion: evaluation using multi-slice computed tomography. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jew032 CrossRefPubMedPubMedCentral

16.

Hayashida K, Lefevre T, Chevalier B et al (2012) Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation. JACC Cardiovasc Interv 5:1247–1256. https://doi.org/10.1016/j.jcin.2012.09.003 CrossRefPubMed

17.

Jilaihawi H, Chen M, Webb J et al (2016) A bicuspid aortic valve imaging classification for the TAVR era. Jacc Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2015.12.022 CrossRefPubMed

18.

Zegdi R, Ciobotaru V, Noghin M et al (2008) Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 51:579–584. https://doi.org/10.1016/j.jacc.2007.10.023 CrossRefPubMed

19.

Lewin MB, Otto CM (2005) The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation 111:832–834. https://doi.org/10.1161/01.CIR.0000157137.59691.0B CrossRefPubMed

20.

Kochman J, Rymuza B, Huczek Z (2015) Transcatheter aortic valve replacement in bicuspid aortic valve disease. Curr Opin Cardiol 30:594–602. https://doi.org/10.1097/HCO.0000000000000219 CrossRefPubMed

21.

Babaliaros VC, Junagadhwalla Z, Lerakis S et al (2010) Use of balloon aortic valvuloplasty to size the aortic annulus before implantation of a balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 3:114–118. https://doi.org/10.1016/j.jcin.2009.09.017 CrossRefPubMed

22.

Popma JJ, Gleason TG, Yakubov SJ et al (2016) Relationship of annular sizing using multidetector computed tomographic imaging and clinical outcomes after self-expanding corevalve transcatheter aortic valve replacement. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003282 CrossRefPubMed

23.

Jilaihawi H, Chin D, Spyt T et al (2011) Comparison of complete versus incomplete stent frame expansion after transcatheter aortic valve implantation with Medtronic CoreValve bioprosthesis. Am J Cardiol 107:1830–1837. https://doi.org/10.1016/j.amjcard.2011.02.317 CrossRefPubMed

24.

Rodriguez-Olivares R, Rahhab Z, Faquir NE et al (2016) Differences in frame geometry between balloon-expandable and self-expanding transcatheter heart valves and association with aortic regurgitation. Rev Espanola Cardiol 69:392–400. https://doi.org/10.1016/j.rec.2015.08.010 CrossRef

25.

Mendiz OA, Fraguas H, Lev GA et al (2013) Transcatheter aortic valve implantation without balloon predilation: a single-center pilot experience. Catheter Cardiovasc Interv 82:292–297. https://doi.org/10.1002/ccd.24805 CrossRefPubMed

26.

Pagnesi M, Jabbour RJ, Latib A et al (2016) Usefulness of predilation before transcatheter aortic valve implantation. Am J Cardiol 118:107–112. https://doi.org/10.1016/j.amjcard.2016.04.018 CrossRefPubMed

Titel: Balloon sizing during transcatheter aortic valve implantation
Comparison of different valve morphologies
verfasst von: Y.-N. Xu, MD
T.-Y. Xiong, MD
Y.-J. Li, MD
Y.-B. Liao, MD
Z.-G. Zhao, MD
X. Wei, MD
Y. Feng, MD
M. Chen, MD, PhD
Publikationsdatum: 05.06.2018
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe 2/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-018-4714-2

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Erratum zu: Primärprävention der koronaren Herzkrankheit

Neue onkologische Therapien und ihre kardiovaskulären Risiken

Darm-Herz-Achse

Neues zur Herzinsuffizienz

Die antagonistische Funktion des Herzmuskels